{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:01:45Z","timestamp":1792119705100,"version":"4.4.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T00:00:00Z","timestamp":1588982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T00:00:00Z","timestamp":1588982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2020,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Overlapping histological features between benign and malignant lesions and a lack of firm diagnostic criteria for malignancy result in high rates of inter-observer variation in the diagnosis of melanocytic lesions. We aimed to investigate the differential expression of five miRNAs (21, 200c, 204, 205, and 211) in benign naevi (<jats:italic>n<\/jats:italic>\u2009=\u200942), dysplastic naevi (<jats:italic>n<\/jats:italic>\u2009=\u200941), melanoma in situ (<jats:italic>n<\/jats:italic>\u2009=\u200942), and melanoma (<jats:italic>n<\/jats:italic>\u00a0=\u200942) and evaluate their potential as diagnostic biomarkers of melanocytic lesions. Real-time PCR showed differential miRNA expression profiles between benign naevi; dysplastic naevi and melanoma in situ; and invasive melanoma. We applied a random forest machine learning algorithm to classify cases based on their miRNA expression profiles, which resulted in a ROC curve analysis of 0.99 for malignant melanoma and greater than 0.9 for all other groups. This indicates an overall very high accuracy of our panel of miRNAs as a diagnostic biomarker of benign, dysplastic, and malignant melanocytic lesions. However, the impact of variable lesion percentage and spatial expression patterns of miRNAs on these real-time PCR results was also considered. In situ hybridisation confirmed the expression of miRNA 21 and 211 in melanocytes, while demonstrating expression of miRNA 205 only in keratinocytes, thus calling into question its value as a biomarker of melanocytic lesions. In conclusion, we have validated some miRNAs, including miRNA 21 and 211, as potential diagnostic biomarkers of benign, dysplastic, and malignant melanocytic lesions. However, we also highlight the crucial importance of considering tissue morphology and spatial expression patterns when using molecular techniques for the discovery and validation of new biomarkers.<\/jats:p>","DOI":"10.1007\/s00428-020-02817-5","type":"journal-article","created":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T22:02:26Z","timestamp":1589061746000},"page":"121-130","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The differential expression of micro-RNAs 21, 200c, 204, 205, and 211 in benign, dysplastic and malignant melanocytic lesions and critical evaluation of their role as diagnostic biomarkers"],"prefix":"10.1007","volume":"477","author":[{"given":"Katherine","family":"Quiohilag","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Caie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anca","family":"Oniscu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Brenn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,9]]},"reference":[{"key":"2817_CR1","unstructured":"Skin Cancer Statistics 2017 [http:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/skin-cancer]"},{"key":"2817_CR2","doi-asserted-by":"crossref","unstructured":"Brenn T. Pitfalls in the evaluation of melanocytic lesions. Oxford, UK2012. p. 690\u2013705","DOI":"10.1111\/j.1365-2559.2011.04042.x"},{"issue":"4","key":"2817_CR3","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1136\/jcp.2004.020933","volume":"58","author":"C Urso","year":"2005","unstructured":"Urso C, Rongioletti F, Innocenzi D, Batolo D, Chimenti S, Fanti PL, Filotico R, Gianotti R, Lentini M, Tomasini C, Pippione M (2005) Histological features used in the diagnosis of melanoma are frequently found in benign melanocytic naevi. J Clin Pathol 58(4):409\u2013412","journal-title":"J Clin Pathol"},{"issue":"4","key":"2817_CR4","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/path.1061","volume":"196","author":"L Brochez","year":"2002","unstructured":"Brochez L, Verhaeghe E, Grosshans E, Haneke E, Pi\u00e9rard G, Ruiter D, Naeyaert JM (2002) Inter-observer variation in the histopathological diagnosis of clinically suspicious pigmented skin lesions. J Pathol 196(4):459\u2013466","journal-title":"J Pathol"},{"issue":"3s","key":"2817_CR5","first-page":"318S","volume":"100","author":"MD Lyn","year":"1993","unstructured":"Lyn MD, Marianne B, Jan AB, Byers HR, Martin CM, Raymond LB (1993) Histopathologic recognition and grading of dysplastic melanocytic nevi: an Interobserver agreement study. J Investig Dermatol 100(3s):318S","journal-title":"J Investig Dermatol"},{"key":"2817_CR6","doi-asserted-by":"publisher","first-page":"j2813","DOI":"10.1136\/bmj.j2813","volume":"357","author":"JG Elmore","year":"2017","unstructured":"Elmore JG, Barnhill RL, Elder DE, Longton GM, Pepe MS, Reisch LM et al (2017) Pathologists' diagnosis of invasive melanoma and melanocytic proliferations: observer accuracy and reproducibility study. BMJ (Clinical research ed) 357:j2813","journal-title":"BMJ (Clinical research ed)"},{"key":"2817_CR7","doi-asserted-by":"crossref","unstructured":"Detassis S, Grasso M, Del Vescovo V, Denti MA (2017) microRNAs make the call in cancer personalized medicine. Front Cell Dev Biol 5","DOI":"10.3389\/fcell.2017.00086"},{"key":"2817_CR8","doi-asserted-by":"crossref","unstructured":"Varamo C, Occelli M, Vivenza D, Merlano M, Lo Nigro C. MicroRNAs role as potential biomarkers and key regulators in melanoma. 2017. p. 3\u201310","DOI":"10.1002\/gcc.22402"},{"issue":"3","key":"2817_CR9","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.suronc.2016.05.017","volume":"25","author":"N Latchana","year":"2016","unstructured":"Latchana N, Ganju A, Howard JH, Carson WE (2016) MicroRNA dysregulation in melanoma. Surg Oncol 25(3):184\u2013189","journal-title":"Surg Oncol"},{"issue":"1\u20132","key":"2817_CR10","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ejcb.2014.02.001","volume":"93","author":"C Luo","year":"2014","unstructured":"Luo C, Weber CEM, Osen W, Bosserhoff A-K, Eichm\u00fcller SB (2014) The role of microRNAs in melanoma. Eur J Cell Biol 93(1\u20132):11\u201322","journal-title":"Eur J Cell Biol"},{"issue":"10","key":"2817_CR11","doi-asserted-by":"publisher","first-page":"4163","DOI":"10.1158\/0008-5472.CAN-09-4512","volume":"70","author":"D Philippidou","year":"2010","unstructured":"Philippidou D, Schmitt M, Moser D, Margue C, Nazarov PV, Muller A, Vallar L, Nashan D, Behrmann I, Kreis S (2010) Signatures of microRNAs and selected microRNA target genes in human melanoma. Cancer Res 70(10):4163\u20134173","journal-title":"Cancer Res"},{"key":"2817_CR12","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ejca.2015.10.009","volume":"53","author":"H Mirzaei","year":"2016","unstructured":"Mirzaei H, Gholamin S, Shahidsales S, Sahebkar A, Jafaari MR, Mirzaei HR et al (2016) MicroRNAs as potential diagnostic and prognostic biomarkers in melanoma. Eur J Cancer 53:25\u201332","journal-title":"Eur J Cancer"},{"issue":"1","key":"2817_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/jpet.117.242636","volume":"364","author":"A Thyagarajan","year":"2018","unstructured":"Thyagarajan A, Shaban A, Sahu RP (2018) MicroRNA-directed cancer therapies: implications in melanoma intervention. J Pharmacol Exp Ther 364(1):1\u201312","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"2817_CR14","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/bjc.2011.568","volume":"106","author":"Y Xu","year":"2012","unstructured":"Xu Y, Brenn T, Brown ERS, Doherty V, Melton DW (2012) Differential expression of microRNAs during melanoma progression: miR-200c, miR-205 and miR-211 are downregulated in melanoma and act as tumour suppressors. Br J Cancer 106(3):553\u2013561","journal-title":"Br J Cancer"},{"issue":"1","key":"2817_CR15","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12943-018-0819-8","volume":"17","author":"M Galasso","year":"2018","unstructured":"Galasso M, Morrison C, Minotti L, Corr\u00e0 F, Zerbinati C, Agnoletto C, Baldassari F, Fassan M, Bartolazzi A, Vecchione A, Nuovo GJ, di Leva G, D\u2019Atri S, Alvino E, Previati M, Nickoloff BJ, Croce CM, Volinia S (2018) Loss of miR-204 expression is a key event in melanoma. Mol Cancer 17(1):71","journal-title":"Mol Cancer"},{"issue":"2","key":"2817_CR16","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/bjd.12989","volume":"171","author":"V Sun","year":"2014","unstructured":"Sun V, Zhou WB, Majid S, Kashani-Sabet M, Dar AA (2014) MicroRNA-mediated regulation of melanoma. Br J Dermatol 171(2):234\u2013241","journal-title":"Br J Dermatol"},{"issue":"5","key":"2817_CR17","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/modpathol.2016.44","volume":"29","author":"S Babapoor","year":"2016","unstructured":"Babapoor S, Horwich M, Wu R, Levinson S, Gandhi M, Makkar H et al (2016) microRNA in situ hybridization for miR-211 detection as an ancillary test in melanoma diagnosis. Mod Pathol 29(5):461","journal-title":"Mod Pathol"},{"issue":"6","key":"2817_CR18","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1038\/labinvest.2017.5","volume":"97","author":"S Babapoor","year":"2017","unstructured":"Babapoor S, Wu R, Kozubek J, Auidi D, Grant-Kels JM, Dadras SS (2017) Identification of microRNAs associated with invasive and aggressive phenotype in cutaneous melanoma by next-generation sequencing. Lab Investig 97(6):636","journal-title":"Lab Investig"},{"key":"2817_CR19","doi-asserted-by":"crossref","unstructured":"James K, Zhihai M, Elizabeth F, Tatiana D, Rong W, Dong-Guk S et al In-depth characterization of microRNA transcriptome in melanoma. PLoS ONE 8(9):e72699","DOI":"10.1371\/journal.pone.0072699"},{"issue":"6","key":"2817_CR20","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.acthis.2011.11.001","volume":"114","author":"L Jiang","year":"2012","unstructured":"Jiang L, Lv X, Li J, Li J, Li X, Li W, Li Y (2012) The status of microRNA-21 expression and its clinical significance in human cutaneous malignant melanoma. Acta Histochem 114(6):582\u2013588","journal-title":"Acta Histochem"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-020-02817-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-020-02817-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-020-02817-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,8]],"date-time":"2021-05-08T23:42:14Z","timestamp":1620517334000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-020-02817-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,9]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["2817"],"URL":"https:\/\/doi.org\/10.1007\/s00428-020-02817-5","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,9]]},"assertion":[{"value":"23 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval for access to FFPE (formalin-fixed paraffin-embedded) archival tissue was gained from the NRS BioResource and Tissue Governance Unit (SR961), and permission to conduct the study was gained from ACCORD via the Integrated Research Application System (IRAS).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}